HOME >> BIOLOGY >> NEWS
Interleukin-12 Helps Control Mycobacterium Avium Infection

Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) have found that treating mice with interleukin-12 (IL-12) plus conventional antibiotic therapy can help control infection with Mycobacterium avium, an opportunistic infection common in people with late-stage AIDS. IL-12, a cytokine or chemical messenger produced by immune cells, helps regulate cell-mediated immunity.

These findings in immunodeficient mice suggest that combined IL-12/drug treatment may offer a highly effective strategy for managing atypical mycobacterial infections in people who have AIDS or are otherwise immunocompromised, note Mark Doherty, Ph.D., and Alan Sher, Ph.D., of NIAID's Laboratory of Parasitic Diseases, in their report published June 1 in the The Journal of Immunology. Furthermore, they postulate that the same approach might work for other opportunistic infections common in these individuals such as Toxoplasma and Histoplasma. Previous research in animals has shown that these infections also respond to IL-12 treatment.

Based on the new findings, researchers at the National Institutes of Health led by Henry Masur, M.D., recently began recruiting people with both AIDS and Mycobacterium avium complex (MAC) into a Phase I clinical trial to test IL-12 in combination with standard antibiotic treatment regimens. MAC is an infection caused by either M. avium or its close relative, M. intracellulare.

"This is an excellent example of how a preclinical study can provide a model for designing a clinical trial," says Anthony S. Fauci, M.D., director of NIAID.

"It's very difficult to treat this infection in AIDS patients," comments Dr. Sher. Often patients have to be treated with three or four different drugs, which can have toxic side effects so that patients become intolerant to one or more drugs. Furthermore, the bacteria that causes the infection can become resistant to one or more antibiotics. This protocol is evaluating a way we might enh
'"/>

Contact: Laurie K. Doepel
ldoepel@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
1-Jun-1998


Page: 1 2 3

Related biology news :

1. Software Helps Decipher Genomes Of Higher Organisms
2. Nutrition Therapy Helps Patients Emotionally, Research Shows
3. ASU Professor Helps In Fight To Protect Japanese Pika Habitat
4. Whitehead Study Supports Existence Of Ancient RNA World, Helps Provide Insight Into Early Evolution Of Life
5. Duke Study Helps Explain How Cells Divvy Up Genes During Reproduction
6. Transplanted Skeletal Muscle Mimics Heart Muscle; Helps Failing Heart Pump, Duke Researchers Say
7. Security Code Helps Immune Cells Attack Foe And Spare Self
8. NASA Research Helps Map Protein Structures -- Key In The Development Of New Disease-Fighting Drugs
9. Auditory Scene Analysis Helps Find Mates
10. UF Researchers Innovative Fence Helps Control Sand Flies
11. Purdue Research Helps Keep Phosphorus Out Of Surface Water

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Interleukin Helps Control Mycobacterium Avium Infection

(Date:8/4/2015)... Aug. 04, 2015 ... has announced the addition of the ... and Service), Sub-Segment (Computer Forensics, Network Forensics, ... Types, Service, Vertical and Region - Global ... offering. By Component (Hardware, Software, ...
(Date:8/4/2015)... Aug. 4, 2015  AMRI (NASDAQ: AMRI ) today reported ... 2015. Highlights: , Second quarter contract revenue ... 2014 , Adjusted contract margins of ... $0.22, including a $0.05 decrease in EPS from royalties in the ... million "We are very pleased to present another ...
(Date:8/3/2015)... SAN JOSE, Calif. , Aug. 3, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that members ... investment community at the Pacific Crest Global Technology Leadership ... Mountain Time. The conference will be held at the ... The presentation may include forward-looking information. ...
Breaking Biology News(10 mins):Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... bushing materials for pumps and process equipment, announces the appointment of Dennis Rawle ... the marine and industrial industries. Most recently, he was General Manager and Technical ...
(Date:8/4/2015)... According to a new ... Cardiac Biomarker - Market Opportunities, and Forecast, 2014-2020", ... revenue of $2,085.9 million by 2020, registering a ... Troponins (T, I) would continue to dominate the ... sensitivity and specificity.      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:8/4/2015)... , Aug. 4, 2015 Trigemina, Inc., ... of non-narcotic, nasally delivered, analgesic drug products, announced today ... to the position of chief medical officer. Dr. Kori ... Trigemina, much of which has been focused in the ... to add Dr. Kori to our clinical team given ...
(Date:8/4/2015)... ... August 04, 2015 , ... RPS ... tests – today announced that Robert A. Gregg, PhD, has joined RPS as ... 30 years of relevant experience and remarkable achievements in the medical device and ...
Breaking Biology Technology:Dennis Rawle Joins Graphite Metallizing Corporation 2Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 2Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 3Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 4Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 5Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 2Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 3RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 2RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 3
Cached News: